Subjects: Biosimilar Pharmaceuticals -- economics - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Biosimilar Pharmaceuticals -- economics

1. A sense of déjà vu: the debate surrounding state biosimilar substitution laws

Author(s):: Purvis, Leigh, author
Publication:: Washington, D.C. : AARP Public Policy Institute, September 2014
Subject(s):: Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
United States
United States. Food and Drug Administration
United States.

2. Assessing user fees under the Biosimilar User Fee Amendments of 2017

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, January 2020
Subject(s):: Biosimilar Pharmaceuticals -- economics
Drug Development -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

3. Assessing user fees under the biosimilar user fee amendments of 2017

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2018
Subject(s):: Biosimilar Pharmaceuticals -- economics
Fees and Charges
Investigational New Drug Application -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration